News Daily News Obstructive CAD Can Be Left Alone Before TAVI, Observational Data Suggest Michael O'Riordan January 30, 2024
Presentation TCT 2023 When Treating Non-LMCA Bifurcations: Should My Strategy Be Different? Presenter: David Hildick-Smith October 25, 2023
News Conference News EuroPCR 2023 For Bifurcation Lesions, It’s OK to Start With Just One Stent: EBC Trials Caitlin E. Cox May 17, 2023
Presentation EuroPCR 2023 The European Bifurcation Club Left Main Coronary Stent study - a randomised comparison of stepwise provisional versus systematic dual stenting strategies (EBC MAIN): 3 year results Presenter: David Hildick-Smith May 16, 2023
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for June 2021 Shelley Wood July 05, 2021
News Conference News EuroPCR 2021 Provisional Stenting Noninferior to Planned Two-Stent Strategy for Left Main Disease: EBC MAIN L.A. McKeown May 21, 2021
Presentation TCT 2020 Provisional Stenting Should Be the Gold Standard, and EBC-MAIN Will Prove It! Presenter: David Hildick-Smith October 17, 2020
News Daily News Better Survival 3 Years After TAVR for Patients With Mixed Aortic Valve Disease L.A. McKeown November 01, 2019
Presentation TCT 2019 TAVR With Concomitant Complex Coronary Disease: Case Presentation and Management Strategies (Chronic CAD vs ACS Syndromes) Presenter: David Hildick-Smith September 26, 2019
Presentation TCT 2019 Strokes After TAVR Are Rare and Cerebral Protection Is Unnecessary Presenter: David Hildick-Smith September 26, 2019
News Conference News EuroPCR 2019 Amplatzer Amulet LAA Closure Device Reduces Stroke Through 2 Years: Global Registry Caitlin E. Cox May 31, 2019
News Conference News EuroPCR 2019 Clip-Based Tricuspid Repair Improves Regurgitation, Function, and Quality of Life: TRILUMINATE Michael O'Riordan May 22, 2019
Presentation TCT 2018 Managing a Busy LAA Closure Program: Patient Selection, Education, Consent, Screening, and Periprocedural Care Presenter: James B. Hermiller Jr, David Hildick-Smith, George S. Hanzel September 24, 2018
Presentation TCT 2018 Adjunctive Pharmacology Following LAA Closure in Anticoagulant Indicated and Contraindicated Patients Presenter: James B. Hermiller Jr, David Hildick-Smith, Martin W. Bergmann September 24, 2018
Presentation TCT 2018 Essential of Pre-procedural Imaging and Intra-procedural Guidance Presenter: James B. Hermiller Jr, David Hildick-Smith, Jacqueline Saw September 24, 2018
Presentation TCT 2018 Shared Decision-making in NVAF: The Patients Perspective Presenter: James B. Hermiller Jr, David Hildick-Smith, Megan Coylewright September 24, 2018
Presentation TCT 2018 Debate: Is LAA Closure a Valid Alternative for Patients with No or Mild Contraindications to Anticoagulants? Yes - LAA Closure Reduces Hemorrhagic Stroke and Mortality And Nearly Everyone Has a Reason Not to Take Oral Anticoagulants! Presenter: James B. Hermiller Jr, David Hildick-Smith, David R. Holmes Jr. September 24, 2018